BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,063 filers reported holding BAXTER INTL INC in Q3 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,867,234 | +29.6% | 243,275 | +62.9% | 0.09% | +49.2% |
| Q4 2022 | $7,612,268 | +175.4% | 149,348 | +191.0% | 0.06% | +173.9% |
| Q3 2022 | $2,764,000 | +216.2% | 51,317 | +277.5% | 0.02% | +187.5% |
| Q2 2022 | $874,000 | -91.9% | 13,595 | -90.2% | 0.01% | -91.8% |
| Q1 2022 | $10,755,000 | +286.2% | 138,700 | +327.6% | 0.10% | +288.0% |
| Q4 2021 | $2,785,000 | +125.1% | 32,439 | +110.8% | 0.02% | +92.3% |
| Q3 2021 | $1,237,000 | -76.4% | 15,385 | -76.4% | 0.01% | -76.8% |
| Q2 2021 | $5,248,000 | +395.6% | 65,187 | +393.8% | 0.06% | +300.0% |
| Q4 2020 | $1,059,000 | -8.9% | 13,200 | -8.7% | 0.01% | -36.4% |
| Q3 2020 | $1,162,000 | -76.1% | 14,458 | -74.3% | 0.02% | -66.2% |
| Q2 2020 | $4,852,000 | +612.5% | 56,352 | +571.8% | 0.06% | +51.2% |
| Q1 2020 | $681,000 | -94.7% | 8,388 | -94.5% | 0.04% | -86.1% |
| Q4 2019 | $12,737,000 | +273.4% | 152,334 | +290.6% | 0.31% | +210.0% |
| Q3 2019 | $3,411,000 | +409.1% | 38,999 | +376.8% | 0.10% | +316.7% |
| Q2 2019 | $670,000 | -68.0% | 8,180 | -68.2% | 0.02% | -67.1% |
| Q1 2019 | $2,092,000 | -48.1% | 25,723 | -58.0% | 0.07% | -52.9% |
| Q4 2018 | $4,029,000 | -56.4% | 61,200 | -49.0% | 0.16% | -62.3% |
| Q3 2018 | $9,251,000 | +65.4% | 120,000 | +39.6% | 0.41% | -2.1% |
| Q1 2018 | $5,592,000 | +111.1% | 85,971 | +109.8% | 0.42% | +93.5% |
| Q4 2017 | $2,649,000 | +94.2% | 40,979 | +88.5% | 0.22% | +73.6% |
| Q3 2017 | $1,364,000 | +210.7% | 21,739 | +103.3% | 0.12% | -30.2% |
| Q1 2016 | $439,000 | – | 10,692 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |